Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers

NCT04614233 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped PI changed institutions

Conditions

Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT: RiduZone (90% OEA)
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]